Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma

(2011) S. Yin et al.   NEURO-ONCOLOGY

Teaching old receptors new tricks: biasing seven-transmembrane receptors

(2010) Sudarshan Rajagopal et al.   NATURE REVIEWS DRUG DISCOVERY

Aberrant intracellular IGF-1R β-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation

(2009) Natalia Natalishvili et al.   EXPERIMENTAL CELL RESEARCH

The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells

(2009) S. B. Coffelt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Differential roles of SS18–SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth

(2008) Maria Törnkvist et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumors Sound the Alarmin(s)

(2008) S. B. Coffelt et al.   CANCER RESEARCH

Identification of c-Cbl as a New Ligase for Insulin-like Growth Factor-I Receptor with Distinct Roles from Mdm2 in Receptor Ubiquitination and Endocytosis

(2008) B. Sehat et al.   CANCER RESEARCH

The insulin receptor substrate-1: A biomarker for cancer?

(2008) Renato Baserga   EXPERIMENTAL CELL RESEARCH

The Human Antimicrobial Peptide LL-37 Suppresses Apoptosis in Keratinocytes

(2008) Clara I. Chamorro et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Microbial Patterns Signaling via Toll-Like Receptors 2 and 5 Contribute to Epithelial Repair, Growth and Survival

(2008) Renat Shaykhiev et al.   PLoS One

The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells

(2007) Judith von Haussen et al.   LUNG CANCER